PAINWeek 2026 is organized by Informa Connect and will be held from Sep 08 - 11, 2026 at The Cosmopolitan of Las Vegas, Las Vegas, Nevada, United States of America.
Description:
The 20th Annual PAINWeek: THE Event in Pain Management
PAINWeek marks its 20th year as the premier US pain conference, offering the most expansive curriculum in pain management. PAINWeek remains the top destination for healthcare professionals eager to enhance their expertise and make a greater impact in the field.
Why Attend the 20th Annual PAINWeek:
01. Celebrate 20 Years of Excellence:
Join us for a milestone anniversary as we continue our legacy as the nation's leading pain management conference.
02. Learn from the Best:
Gain insights from top experts and access the latest evidence-based strategies in pain care.
03. Earn Valuable CME Credits:
Advance your professional development while staying current with accreditation requirements.
04. Discover Innovative Solutions:
Explore cutting-edge technologies and therapies in our comprehensive exhibit hall.
05. Network with Your Peers:
Connect with fellow clinicians who share your commitment to improving patient outcomes.
Educational Objectives:
Upon completion of this activity, participants should be able to:
PAINWeek 2026 offers credit through the following boards:
Jointly provided by Partners for Advancing Clinical Education and Informa Connect
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Informa Connect Medical. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education:
Partners designates this live activity for a maximum of 23 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development:
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 23 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Pharmacy Continuing Education:
Partners designates this continuing education activity for 23 contact hour(s) (2.3 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008073-9999-26-010-L08-P)
Type of Activity: Knowledge
PA Continuing Medical Education
Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 23 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Psychologist Continuing Education:
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation:
This program offers 23 continuing education credits for psychologists.
Social Work Continuing Education:
As a Jointly Accredited Organization, Partners for Advancing Clinical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 23 Clinical continuing education credits.
Physical Therapy Continuing Education:
Information coming soon!
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Faculty and Disclosure of Conflicts of Interest
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved